Intercept Pharmaceuticals

+$0.32 (+2.09%) As of 5:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ICPT and other ETFs, options, and stocks.

About ICPT

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases.

CEO

Jerome B. Durso

Employees

437

Headquarters

Morristown, New Jersey

Founded

2002

ICPT Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

579.46K

High today

$15.83

Low today

$13.33

Open price

$13.35

Volume

2.01M

52 Week high

$20.50

52 Week low

$10.81

ICPT News

MarketWatch5h

Intercept Reports More Positive Phase 3 Data From NASH Study >ICPT - MarketWatch

By Colin Kellaher Intercept Pharmaceuticals Inc. on Thursday reported positive topline results from an interim analysis of its pivotal Phase 3 study of its pro

Analyst ratings

Buy

33.3%

Hold

53.3%

Sell

13.3%

ICPT Earnings

-$1.58

-$1.05

-$0.53

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Jul 28, Pre-Market

Why Robinhood?

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. View more

Intercept Reports More Positive Phase 3 Data From NASH Study >ICPT - MarketWatch

53%

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases.